Clear Cell Renal Cell Carcinoma — Trials

Clear Cell Renal Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

247 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 114
Recruiting: 62
Ph III recruiting: 6
Growth YoY: −11.4%
Industry share: 30%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 44%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (39)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03473730	Daratumumab in Treating Patients with Muscle Invasive Bladder Cancer or Metastatic Kidney Cancer	completed	Early Phase 1	17	M.D. Anderson Cancer CenterOTHER	1	Jan 30, 2025	clinicaltrials
NCT05728515	A Small-molecule Carbonic Anhydrase IX Targeting PET Tracer in Clear Cell Renal Cell Carcinoma	completed	Early Phase 1	3	Peking Union Medical College HospitalOTHER	1	Feb 15, 2023	clinicaltrials